Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Takeda Pharmaceutical Company (TAK)
NYSE:TAK
RESEARCH TOOLSreports
Holding TAK?
Track your performance easily
TAK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$12.58 - $15.08
Previous CloseN/A
Volume1.19M
Average Volume (3M)1.72M
Market Cap
$41.28B
Enterprise Value$75.10B
Total Cash (Recent Filing)$376.14B
Total Debt (Recent Filing)$599.86B
Price to Earnings (P/E)21.4
Beta0.25
Next Earnings
Jan 30, 2025EPS Estimate
0.09Last Dividend Ex-Date
Sep 30, 2024Dividend Yield3.86%
Share Statistics
EPS (TTM)0.61
Shares Outstanding3,181,875,200
10 Day Avg. Volume2,098,078
30 Day Avg. Volume1,720,668
Standard Deviation0.06
R-Squared0.17
Alpha-0.00657
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.52
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.82
Enterprise Value/Revenue0.04
Enterprise Value/Gross Profit0.03
Enterprise Value/Ebitda0.12
Forecast
1Y Price Target
$14.80Price Target Upside13.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Takeda Pharmaceutical Company News
PremiumCompany Announcements
Takeda Announces Subsidiary Liquidation and Merger Completion
Ownership Overview
―
Insiders
0.43% Mutual Funds
0.01% Other Institutional Investors
99.36% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TAK FAQ
What was Takeda Pharmaceutical Company’s price range in the past 12 months?
Takeda Pharmaceutical Company lowest stock price was $12.57 and its highest was $15.08 in the past 12 months.
What is Takeda Pharmaceutical Company’s market cap?
Takeda Pharmaceutical Company’s market cap is $41.28B.
When is Takeda Pharmaceutical Company’s upcoming earnings report date?
Takeda Pharmaceutical Company’s upcoming earnings report date is Jan 30, 2025 which is in 12 days.
How were Takeda Pharmaceutical Company’s earnings last quarter?
Takeda Pharmaceutical Company released its earnings results on Oct 31, 2024. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.124 by $0.066.
Is Takeda Pharmaceutical Company overvalued?
According to Wall Street analysts Takeda Pharmaceutical Company’s price is currently Undervalued.
Does Takeda Pharmaceutical Company pay dividends?
Takeda Pharmaceutical Company pays a Semiannually dividend of $0.632 which represents an annual dividend yield of 3.86%. See more information on Takeda Pharmaceutical Company dividends here
What is Takeda Pharmaceutical Company’s EPS estimate?
Takeda Pharmaceutical Company’s EPS estimate is 0.09.
How many shares outstanding does Takeda Pharmaceutical Company have?
Takeda Pharmaceutical Company has 3,181,875,200 shares outstanding.
What happened to Takeda Pharmaceutical Company’s price movement after its last earnings report?
Takeda Pharmaceutical Company reported an EPS of $0.19 in its last earnings report, beating expectations of $0.124. Following the earnings report the stock price went up 0.36%.
Which hedge fund is a major shareholder of Takeda Pharmaceutical Company?
Currently, no hedge funds are holding shares in TAK
---
Takeda Pharmaceutical Company Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.80 (13.41% Upside)
$14.80 (13.41% Upside)
Blogger Sentiment
Bullish
TAK Sentiment 80%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 540.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.2%
Last 30 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.05%
12-Months-Change
Fundamentals
Return on Equity
4.02%
Trailing 12-Months
Asset Growth
2.23%
Trailing 12-Months
Company Description
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company Limited is engaged in the research and development, manufacturing, marketing, and importing and exporting of pharmaceutical drugs and other healthcare products. The company offers pharmaceutical products in the areas of oncology, neuroscience, gastroenterology, and rare diseases.
---
TAK Company Deck
---
TAK Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed performance with notable achievements in product launches and pipeline progress, offset by challenges from generic competition and profit declines. While growth in new products is promising, the financial impact of loss of exclusivity on core products remains a concern.Read More>---
TAK Stock 12 Month Forecast
Average Price Target
$14.80
▲(13.41% Upside)
Technical Analysis
Best Analysts Covering TAK
1 Year
1 Year Success Rate
0/5 ratings generated profit
1 Year Average Return
-4.96%
reiterated a buy rating last month
Copying Michael Nedelcovych's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -4.96% per trade.
---